stockrow
Saturday 7 November 2026
Export LNAI’s income statement to Excel — free account
Lunai Bioworks Inc.
LNAI Healthcare Biotechnology
Lunai Bioworks Inc.’s revenue for fiscal 2026 (year ended June 2026) was $52,000.00.
- EPS
- +99.0%
- Free cash flow
- −1.65%
Quarter to June 2026, against a year earlier
0.16
0.00
0.00%
Follow LNAI
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 23.46% | (325.46%) | (366.44%) | (308.01%) |
+8 more TTM periods Free account |
|
| (39.21%) | (201.09%) | (212.74%) | (203.39%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
21.13% | 825.67% | 644.58% | 692.65% | |
Average Days of Receivables |
0.00 | — | — | — | |
Free Cash Flow per Share |
(1.58) | (1.69) | (1.97) | (2.56) | |
Free Cash Flow |
(5.31) | (5.29) | (5.79) | (7.21) | |
Capital Expenditures |
(0.02) | (0.03) | (0.07) | — | |
| Other line items | |||||
Cash ROIC |
72.67% | 82.65% | 44.35% | 58.05% | |
Accounts Receivable Turnover |
0.00 | — | — | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
25.87% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8,236.54% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(40.46) | (315.03) | (270.10) | (288.43) | |
Operating CF/Net income |
1.48 | 0.04 | 0.05 | 0.06 | |
Depreciation/Fixed assets |
14.46 | 9,460.75 | 9,246.65 | 13,646.76 | |
Capex/Depreciation |
(0.14) | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.03 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.57) | (1.68) | (1.95) | (2.56) | |
Capex per Share |
(0.01) | (0.01) | (0.02) | 0.00 | |
Capex to Sales |
0.26 | 0.00 | 0.00 | — |
Columns are period end dates · fundamentals updated 2 Nov 2026